Coronavirus disease 2019 (COVID-19) may have a wide spectrum of clinical presentations,
leading in some cases to a critical condition with poor long-term outcomes and residual …

Background Studies have suggested that there is increased risk of thromboembolism (TE)
associated with coronavirus disease 2019 (COVID-19). However, overall arterial and …

Venous thromboembolic complications have emerged as serious sequelae in COVID-19
infections. This article summarizes the most current information regarding pathophysiology …

Background Individual studies have reported widely variable rates for VTE and bleeding
among hospitalized patients with coronavirus disease 2019 (COVID-19). Research Question …

Introduction Infection with SARS-CoV-2 is typically compared with influenza to contextualize
its health risks. SARS-CoV-2 has been linked with coagulation disturbances including …

Abstract Coronavirus disease‐19 (COVID‐19) started in Wuhan, China in December 2019
and spread to all around the world in a short period of time. Hospitalized patients with …

Background A high incidence of venous thromboembolism (VTE) in COVID-19 has led to
international recommendations for thromboprophylaxis. With limited data on Asian patients …

Abstract Coronavirus disease 2019 (COVID-19) has affected more than 6 million patients
worldwide. Deep venous thrombosis (DVT) has been increasingly recognized complication …

Background Few data are available on the rate and characteristics of thromboembolic
complications in hospitalized patients with COVID-19. Methods We studied consecutive …

Background COVID-19 appears to be associated with a high risk of venous
thromboembolism (VTE). We aimed to systematically review and meta-analyze the risk of …